In the TME, CCL2 secreted by cancer cells and stromal cells can activate downstream pathways, up-regulate the expression of anti-apoptotic proteins and cell cycle regulatory proteins to promote the survival and anti-apoptotic ability of tumor cells (Figure 4). The gene discussed is CCL2; the disease is neoplasm.